Qinfen Yu

910 total citations
11 papers, 665 citations indexed

About

Qinfen Yu is a scholar working on Surgery, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Qinfen Yu has authored 11 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Pharmacology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Qinfen Yu's work include Inflammatory mediators and NSAID effects (4 papers), Lipoproteins and Cardiovascular Health (3 papers) and Drug-Induced Adverse Reactions (2 papers). Qinfen Yu is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Lipoproteins and Cardiovascular Health (3 papers) and Drug-Induced Adverse Reactions (2 papers). Qinfen Yu collaborates with scholars based in United States, Canada and Australia. Qinfen Yu's co-authors include Alise Reicin, Claire Bombardier, Loren Laine, Thomas J. Schnitzer, L. Connors, Christopher J. Hawkey, Deborah R. Shapiro, Rhoda Sperling, Eliav Barr and John F. Paolini and has published in prestigious journals such as Gastroenterology, The American Journal of Cardiology and International Journal of Obesity.

In The Last Decade

Qinfen Yu

11 papers receiving 627 citations

Peers

Qinfen Yu
Barbara Tournier United States
B. Mellein Switzerland
Rasmus S. Pedersen Denmark
Sung Eun Sim South Korea
Lourdes Vendrell Spain
Aida Yared United States
S H Roth United States
SoJeong Yi South Korea
Marianne Kristiansen Kringen Norway
James C. Kisicki United States
Barbara Tournier United States
Qinfen Yu
Citations per year, relative to Qinfen Yu Qinfen Yu (= 1×) peers Barbara Tournier

Countries citing papers authored by Qinfen Yu

Since Specialization
Citations

This map shows the geographic impact of Qinfen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinfen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinfen Yu more than expected).

Fields of papers citing papers by Qinfen Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinfen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinfen Yu. The network helps show where Qinfen Yu may publish in the future.

Co-authorship network of co-authors of Qinfen Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Qinfen Yu. A scholar is included among the top collaborators of Qinfen Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinfen Yu. Qinfen Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Proietto, Joseph, A Rissanen, Joyce B. Harp, et al.. (2010). A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study. International Journal of Obesity. 34(8). 1243–1254. 59 indexed citations
2.
Paolini, John F., Yale Mitchel, Rafael Reyes, et al.. (2008). Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire©: results from a randomised placebo-controlled clinical trial. International Journal of Clinical Practice. 62(6). 896–904. 14 indexed citations
3.
Maccubbin, Darbie, Harold Bays, Anders Olsson, et al.. (2008). Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia. International Journal of Clinical Practice. 62(12). 1959–1970. 90 indexed citations
4.
Navarra, Sandra, Bernard R. Rubin, Qinfen Yu, Steven S. Smugar, & Andrew M. Tershakovec. (2007). Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout. Current Medical Research and Opinion. 23(7). 1685–1691. 13 indexed citations
5.
Norquist, Josephine M., Douglas J. Watson, Qinfen Yu, et al.. (2007). Validation of a questionnaire to assess niacin-induced cutaneous flushing. Current Medical Research and Opinion. 23(7). 1549–1560. 44 indexed citations
6.
Maccubbin, Darbie, Waheeda Sirah, Olga Kuznetsova, et al.. (2007). Flushing Profile of ER Niacin/Laropiprant in Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia. 1 indexed citations
7.
Curtis, Sean, Jennifer Ng, Qinfen Yu, et al.. (2004). Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials. Clinical Therapeutics. 26(1). 70–83. 49 indexed citations
8.
Becker, Allan B., Arlene S. Swern, Carol A. Tozzi, et al.. (2004). Montelukast in asthmatic patients 6 years–14 years old with an FEV1> 75%. Current Medical Research and Opinion. 20(10). 1651–1659. 16 indexed citations
9.
Watson, Douglas J., Qinfen Yu, James A. Bolognese, Alise Reicin, & Thomas Simon. (2004). The upper gastrointestinal safety of rofecoxib vs. NSAIDs: an updated combined analysis*. Current Medical Research and Opinion. 20(10). 1539–1548. 33 indexed citations
10.
Laine, Loren, L. Connors, Alise Reicin, et al.. (2003). Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology. 124(2). 288–292. 247 indexed citations
11.
Reicin, Alise, Deborah R. Shapiro, Rhoda Sperling, Eliav Barr, & Qinfen Yu. (2002). Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with Rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (Ibuprofen, Diclofenac, and Nabumetone). The American Journal of Cardiology. 89(2). 204–209. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Tournier Breakdown of academic impact, for papers by B. Mellein Breakdown of academic impact, for papers by Rasmus S. Pedersen Breakdown of academic impact, for papers by Sung Eun Sim Breakdown of academic impact, for papers by Lourdes Vendrell Breakdown of academic impact, for papers by Aida Yared Breakdown of academic impact, for papers by S H Roth Breakdown of academic impact, for papers by SoJeong Yi Breakdown of academic impact, for papers by Marianne Kristiansen Kringen Breakdown of academic impact, for papers by James C. Kisicki
Rankless by CCL
2026